Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation

Yuxin Liu, Yi Ching Lo, Li Qian, Fulton Tim Crews, Belinda Wilson, Hui Ling Chen, Hung Ming Wu, Shih Heng Chen, Ke Wei, Ru Band Lu, Syed Ali, Jau Shyong Hong

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Verapamil has been shown to be neuroprotective in several acute neurotoxicity models due to blockade of calcium entry into neurons. However, the potential use of verapamil to treat chronic neurodegenerative diseases has not been reported. Using rat primary mesencephalic neuron/glia cultures, we report that verapamil significantly inhibited LPS-induced dopaminergic neurotoxicity in both pre- and post-treatment experiments. Reconstituted culture studies revealed that the presence of microglia was essential in verapamil-elicited neuroprotection. Mechanistic studies showed that decreased production of inflammatory mediators from LPS-stimulated microglia underlay neuroprotective property of verapamil. Further studies demonstrated that microglial NADPH oxidase (PHOX), the key superoxide-producing enzyme, but not calcium channel in neurons, is the site of action for the neuroprotective effect of verapamil. This conclusion was supported by the following two observations: 1) Verapamil failed to show protective effect on LPS-induced dopaminergic neurotoxicity in PHOX-deficient (deficient in the catalytic subunit of gp91 phox) neuron/glia cultures; 2) Ligand binding studies showed that the binding of [ 3H]Verapamil onto gp91 phox transfected COS7 cell membranes was higher than the non-transfected control. The calcium channel-independent neuroprotective property of verapamil was further supported by the finding that R(+)-verapamil, a less active form in blocking calcium channel, showed the same potency in neuroprotection, inhibition of pro-inflammatory factors production and binding capacity to gp91 phox membranes as R(-)-verapamil, the active isomer of calcium channel blocker. In conclusion, our results demonstrate a new indication of verapamil-mediated neuroprotection through a calcium channel-independent pathway and provide a valuable avenue for the development of therapy for inflammation-related neurodegenerative diseases.

Original languageEnglish
Pages (from-to)373-380
Number of pages8
JournalNeuropharmacology
Volume60
Issue number2-3
DOIs
Publication statusPublished - 2011 Feb 1

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation'. Together they form a unique fingerprint.

  • Cite this

    Liu, Y., Lo, Y. C., Qian, L., Crews, F. T., Wilson, B., Chen, H. L., Wu, H. M., Chen, S. H., Wei, K., Lu, R. B., Ali, S., & Hong, J. S. (2011). Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology, 60(2-3), 373-380. https://doi.org/10.1016/j.neuropharm.2010.10.002